Skip to main content
. 2010 Apr;69(4):379–390. doi: 10.1111/j.1365-2125.2009.03600.x

Figure 4.

Figure 4

Number of adverse events vs. score values from a subsequent one-component model of initial principal component analysis results for regimen ‘5+9’. The size of the point reflects dose level for the respective patient. (a) Number of fatigue events. (b) Number of pyrexia events